Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05725174 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Volatile Non-Invasive Biomarkers of Epileptic Seizures

Study acronym: VIBES
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 6, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Feb 1, 2025 to Oct 1, 2025
    • Study completion date: Feb 1, 2026 to Nov 1, 2026
    • Site details revised at 1 of 2 sites
    v3
  2. Study description expanded, about 71 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Breath and sweat samples will be collected from people who have been admitted to hospital after a potential seizure and analysed by the team. The researchers then hope to identify a pattern of small molecules that can distinguish seizures from other events, and perhaps determine the severity of the seizure.
Trial Details
NCT Number NCT05725174
Lead Sponsor University College London Hospitals
Collaborators: Imperial College London
Conditions
(from sponsor)		 Epilepsy, Non-Epileptic Seizure
Related terms Epilepsy, Seizures
Enrollment 270 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov